![Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals | Nature Medicine Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01413-7/MediaObjects/41591_2021_1413_Fig1_HTML.png)
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals | Nature Medicine
![Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave | Nature Medicine Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-02138-x/MediaObjects/41591_2022_2138_Fig1_HTML.png)
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave | Nature Medicine
![COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit](https://www.natap.org/2022/images/021622/021622-16/0216224.gif)
COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit
![Vaccines | Free Full-Text | Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic Vaccines | Free Full-Text | Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic](https://www.mdpi.com/vaccines/vaccines-10-00755/article_deploy/html/images/vaccines-10-00755-g001.png)
Vaccines | Free Full-Text | Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
![Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants | Science Immunology Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abn8014/asset/a0990b68-1995-4ee1-a80c-ff69749a4125/assets/images/large/sciimmunol.abn8014-f2.jpg)
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants | Science Immunology
![HKUMed reports that timely booster vaccination reduces Omicron breakthrough infections and COVID-19 severity - All News - Media - HKU HKUMed reports that timely booster vaccination reduces Omicron breakthrough infections and COVID-19 severity - All News - Media - HKU](https://www.hku.hk/f/news/25661/900p600/20230104_graphics_Eng.jpg)
HKUMed reports that timely booster vaccination reduces Omicron breakthrough infections and COVID-19 severity - All News - Media - HKU
![Breakthrough COVID-19 infections and deaths rose during delta, but far outpaced by the unvaccinated - ABC News Breakthrough COVID-19 infections and deaths rose during delta, but far outpaced by the unvaccinated - ABC News](https://s.abcnews.com/images/US/Chart_CumulativeBreakthroughCases_v02_sd_1640016148924_hpEmbed_1x1_992.jpg)
Breakthrough COVID-19 infections and deaths rose during delta, but far outpaced by the unvaccinated - ABC News
![COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit](https://www.natap.org/2022/images/021622/021622-16/0216223.gif)
COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit
![Vaccines | Free Full-Text | Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave Vaccines | Free Full-Text | Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave](https://www.mdpi.com/vaccines/vaccines-11-00447/article_deploy/html/images/vaccines-11-00447-g001.png)
Vaccines | Free Full-Text | Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave
![Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) - The Lancet Regional Health – Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) - The Lancet Regional Health –](https://www.thelancet.com/cms/asset/d066fc5c-4ee6-4a13-8a4e-f59d0337daef/gr2.jpg)
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) - The Lancet Regional Health –
![SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact | Nature Reviews Immunology SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-021-00662-4/MediaObjects/41577_2021_662_Fig1_HTML.png)
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact | Nature Reviews Immunology
![Frontiers | Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It Frontiers | Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It](https://www.frontiersin.org/files/MyHome%20Article%20Library/858006/858006_Thumb_400.jpg)
Frontiers | Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
![Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2 | Nature Medicine Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2 | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-021-01575-4/MediaObjects/41591_2021_1575_Fig1_HTML.png)